Tag: biosimilars

Healthcare System Savings: How Generic Drugs Cut Billions in U.S. Drug Spending

Healthcare System Savings: How Generic Drugs Cut Billions in U.S. Drug Spending

Generic drugs saved $482 billion in U.S. healthcare spending in 2024, making up 90% of prescriptions but only 12% of costs. Biosimilars are the next frontier, with potential to save hundreds of billions more-if barriers to entry are removed.

Jan 28 2026
Biologic Drugs: Why They Can't Be Copied Like Regular Pills

Biologic Drugs: Why They Can't Be Copied Like Regular Pills

Biologic drugs are made from living cells, not chemicals - that’s why they can’t be copied like regular pills. Biosimilars offer similar benefits at lower costs, but exact copies are impossible due to biological complexity.

Jan 12 2026